Kristina Gruden

Title: Innovations of Kristina Gruden in Recombinant Protein Expression

Introduction

Kristina Gruden is a notable inventor based in Ljubljana, Slovenia. She has made significant contributions to the field of recombinant protein expression, holding 2 patents that focus on improving the efficiency and stability of protein production.

Latest Patents

Her latest patents include "Predicting genetically stable recombinant protein production in early cell line development" and "Predicting productivity in early cell line development." The first patent relates to a method for selecting suitable candidate cell clones for recombinant protein expression, utilizing host cells with modified gene expression. The second patent also focuses on selecting candidate cell clones, emphasizing the importance of gene expression in enhancing productivity.

Career Highlights

Kristina Gruden is currently employed at Lek Pharmaceuticals D.d., where she continues to innovate in the field of biotechnology. Her work is pivotal in advancing the methods used for recombinant protein production, which has significant implications for pharmaceuticals and biotechnology.

Collaborations

She collaborates with esteemed colleagues such as Uros Jamnikar and Marjanca Blas, contributing to a dynamic research environment that fosters innovation and development.

Conclusion

Kristina Gruden's work in recombinant protein expression exemplifies the impact of innovative thinking in biotechnology. Her patents and collaborations highlight her commitment to advancing the field and improving production methods.